… Serum samples from the PARIS … serum samples from 54 participants. Twenty out of 54
participants were seronegative prior to vaccination while 34/54 had COVID-19 prior to vaccination (…

… to both BNT162b2 vaccination and natural infection. We find that vaccinated serum is less
… B.1.351 than early lineage SARS-CoV-2, and that convalescent serum is less neutralizing …

… recipients of the BNT162b2 vaccine against isolates of the major SARS-CoV-2 lineages …
vaccine dose, serum samples of vaccinees were able to neutralize efficiently all SARS-CoV-2 …

… Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has undergone … Here we
study the ability of monoclonal antibodies and convalescent and vaccine sera to neutralize B.…

… after SARS-CoV-2 booster vaccination and age distribution of the groups used in this study.
a) SARS-CoV-2 … b) Age distribution of the serum donors grouped by vaccination scheme and …

… After the second vaccination, serum-neutralizing activity was … of a panel of control convalescent
serum specimens. Solicited … common after the second vaccination, particularly with the …

… Serum antibody titers were significantly lower against Omicron RBD compared to the …
observed for serum of 2× BNT162b2-vaccinated persons. Neutralization of Omicron SARS-CoV-2 …

… of BA.4/5 using a range of vaccine and naturally immune serum and panels of monoclonal
… by the serum from individuals vaccinated with triple doses of AstraZeneca or Pfizer vaccine …

… The rapidly emerging SARS-CoV-2 omicron variant is associated with high
transmissibility, compromised serum neutralising activity, and reduced vaccine effectiveness. …

… All 24 serum samples from either recipients of BBIBP-CorV … For both vaccines, immune serum
samples neutralise both variant … -based vaccine against authentic virus and mRNA vaccine …